Co-Diagnostics Market Cap

Co-Diagnostics has a market cap or net worth of 3.89 million as of February 12, 2026. Its market cap has decreased by -80.64% in one year.

Market Cap

3.89M

Enterprise Value

-3.43M

Revenue

377.84K

Ranking

n/a

PE Ratio

n/a

Stock Price

2.29

Market Cap Chart

Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 3.89M, a decrease of -92.76%. That is a compound annual growth rate of -26.33%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	3.89M	-49.06%
Dec 31, 2025	7.63M	-60.12%
Dec 31, 2024	19.13M	-40.10%
Dec 29, 2023	31.93M	-50.62%
Dec 30, 2022	64.66M	-66.38%
Dec 31, 2021	192.31M	-0.13%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 12, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
capAI	4.33M
Aterian	4.28M
Bay Capital	4.20M
Vox Valor Capital	4.18M
DeFi Development Corporation UK	3.95M
World Chess	3.82M
Thalassa Holdings	3.66M
British & American Investment Trust	3.63M

Market Cap Rankings